3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Lymph Node Metastasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldini, MT; Buraggi, GL; Cascinelli, N; Castellani, MR; Gasparini, M; Maffioli, L; Mascheroni, L; Mongioj, V; Seregni, E | 1 |
| Baldini, M; Castellani, MR; Clemente, C; Maffioli, LS; Mascheroni, L | 1 |
| Bida, B; Henker, C; Markwardt, J; Schlag, P | 1 |
1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Lymph Node Metastasis
| Article | Year |
|---|---|
Scintigraphic detection of melanoma metastases with a radiolabeled benzamide ([iodine-123]-(S)-IBZM).
Topics: Adult; Aged; Aged, 80 and over; Benzamides; Contrast Media; Dopamine Antagonists; Evaluation Studies as Topic; Female; Humans; Iodine Radioisotopes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Pyrrolidines; Radiation Dosage; Skin Neoplasms; Tomography, Emission-Computed, Single-Photon | 1994 |
2 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Lymph Node Metastasis
| Article | Year |
|---|---|
[123I]IBZM uptake in metastatic melanoma.
Topics: Aged; Benzamides; Female; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Melanoma; Pyrrolidines; Radionuclide Imaging | 1993 |
[Diagnostic value of 123iodine-ibzm scintigraphy for staging of malignant melanomas].
Topics: Benzamides; Brain Neoplasms; Dopamine Antagonists; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Magnetic Resonance Imaging; Melanoma; Neoplasm Metastasis; Neoplasm Staging; Pyrrolidines; Radionuclide Imaging; Skin Neoplasms; Tomography, X-Ray Computed | 1997 |